Physician profile
Narinder K Brar
NPI 1902863350
$4,078.53
in general payments reported to CMS, 2019-2025
48 companies · $500 in 2025
The $500 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $311 · 2021: $654 · 2022: $710 · 2023: $702 · 2024: $649 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,811 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,810.52 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $854.86 | 2019-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $405.69 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $188.10 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $182.40 | 2021-2025 | Slynd |
| Philips North America LLC | $174.74 | 2019-2020 | |
| Myriad Women'S Health, INC. | $157.69 | 2023 | Myrisk |
| Millicent US INC | $153.21 | 2019-2025 | Femring, Intrarosa |
| Daiichi Sankyo INC. | $145.51 | 2021-2022 | |
| Hologic Sales and Service, LLC | $103.64 | 2023-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Momentis Surgical INC. | $102.00 | 2022 | |
| Shield Therapeutics INC | $100.55 | 2023-2025 | Accrufer |
| Merck Sharp & Dohme LLC | $98.34 | 2019-2024 | Gardasil, Gardasil 9 |
| Sunovion Pharmaceuticals INC. | $95.55 | 2019 | |
| Organon LLC | $88.29 | 2021-2025 | Nexplanon, Jada System |
| Mayne Pharma Commercial LLC | $86.98 | 2021-2025 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narinder Brar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.